Ray Dalio's CAH Position Overview
Ray Dalio (via Bridgewater Associates, Lp) currently holds 216,669 shares of Cardinal Health, Inc. (CAH) worth $44.53 M, representing 0.16% of the portfolio. First purchased in 2013-Q2, this long-term strategic position has been held for 49 quarters.
Based on 13F filings since 2013, Ray Dalio has maintained a long-term strategic position in CAH, representing a significant commitment to this investment thesis. Largest addition occurred in Q4 2018, adding 603,494 shares. Largest reduction occurred in Q3 2018, reducing 574,357 shares.
Analysis based on 13F filings available since 2013 Q2
Ray Dalio's Cardinal Health (CAH) Holding Value Over Time
Track share changes against reported price movement
Quarterly Cardinal Health (CAH) Trades by Ray Dalio
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q4 2025 | -55,364 | Reduce 20.35% | 216,669 | $205.50 |
| Q3 2025 | +13,278 | Add 5.13% | 272,033 | $156.96 |
| Q2 2025 | +186,472 | Add 257.97% | 258,755 | $168.00 |
| Q1 2025 | -336,472 | Reduce 82.32% | 72,283 | $137.77 |
| Q4 2024 | -56,504 | Reduce 12.14% | 408,755 | $118.27 |
| Q3 2024 | -5,557 | Reduce 1.18% | 465,259 | $110.52 |
| Q2 2024 | -80,612 | Reduce 14.62% | 470,816 | $98.32 |
| Q1 2024 | +133,009 | Add 31.79% | 551,428 | $111.90 |
| Q4 2023 | -42,581 | Reduce 9.24% | 418,419 | $100.80 |
| Q3 2023 | +171,038 | Add 58.99% | 461,000 | $86.82 |
| Q2 2023 | +81,028 | Add 38.78% | 289,962 | $94.57 |
| Q1 2023 | -31,050 | Reduce 12.94% | 208,934 | $75.50 |
| Q4 2022 | +172,026 | Add 253.14% | 239,984 | $76.87 |
| Q3 2022 | -446,545 | Reduce 86.79% | 67,958 | $66.67 |
| Q2 2022 | +105,553 | Add 25.81% | 514,503 | $52.27 |
| Q1 2022 | +84,341 | Add 25.98% | 408,950 | $56.70 |
| Q4 2021 | +29,349 | Add 9.94% | 324,609 | $51.49 |
| Q3 2021 | +9,927 | Add 3.48% | 295,260 | $49.46 |
| Q2 2021 | +121,240 | Add 73.88% | 285,333 | $57.09 |
| Q1 2021 | +14,477 | Add 9.68% | 164,093 | $60.75 |
| Q4 2020 | +78,954 | Add 111.73% | 149,616 | $53.56 |
| Q3 2020 | +65,634 | Add 1305.37% | 70,662 | $46.96 |
| Q2 2020 | -3,275 | Reduce 39.44% | 5,028 | $52.11 |
| Q1 2020 | +8,303 | New Buy | 8,303 | $47.93 |
| Q4 2019 | -349,452 | Sold Out | 0 | $0.00 |
| Q3 2019 | -125,851 | Reduce 26.48% | 349,452 | $47.19 |
| Q2 2019 | -61,315 | Reduce 11.43% | 475,303 | $47.10 |
| Q1 2019 | -245,425 | Reduce 31.38% | 536,618 | $48.15 |
| Q4 2018 | +603,494 | Add 338.00% | 782,043 | $44.60 |
| Q3 2018 | -574,357 | Reduce 76.29% | 178,549 | $54.00 |
| Q2 2018 | +146,124 | Add 24.08% | 752,906 | $48.83 |
| Q1 2018 | +131,090 | Add 27.56% | 606,782 | $62.68 |
| Q4 2017 | +475,692 | New Buy | 475,692 | $61.27 |
| Q2 2017 | -46,958 | Sold Out | 0 | $0.00 |
| Q1 2017 | -77,042 | Reduce 62.13% | 46,958 | $81.54 |
| Q4 2016 | +26,743 | Add 27.50% | 124,000 | $71.97 |
| Q3 2016 | -46,324 | Reduce 32.26% | 97,257 | $77.70 |
| Q2 2016 | +50,149 | Add 53.67% | 143,581 | $78.01 |
| Q1 2016 | +29,100 | Add 45.23% | 93,432 | $81.95 |
| Q4 2015 | -26,400 | Reduce 29.10% | 64,332 | $89.27 |
| Q3 2015 | -18,568 | Reduce 16.99% | 90,732 | $76.82 |
| Q2 2015 | +39,300 | Add 56.14% | 109,300 | $83.65 |
| Q1 2015 | +70,000 | New Buy | 70,000 | $90.27 |
| Q3 2014 | -10,834 | Sold Out | 0 | $0.00 |
| Q2 2014 | -38,010 | Reduce 77.82% | 10,834 | $68.58 |
| Q1 2014 | +23,198 | Add 90.45% | 48,844 | $69.98 |
| Q4 2013 | -49,700 | Reduce 65.96% | 25,646 | $66.79 |
| Q3 2013 | +29,000 | Add 62.57% | 75,346 | $52.15 |
| Q2 2013 | +46,346 | Add 0.00% | 46,346 | $47.21 |
Ray Dalio's Cardinal Health Investment FAQs
Ray Dalio first purchased Cardinal Health, Inc. (CAH) in Q2 2013, acquiring 46,346 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Ray Dalio has held Cardinal Health, Inc. (CAH) for 49 quarters since Q2 2013.
Ray Dalio's largest addition to Cardinal Health, Inc. (CAH) was in Q4 2018, adding 782,043 shares worth $34.88 M.
According to the latest 13F filing for Q4 2025, Ray Dalio's firm, Bridgewater Associates, Lp, owns 216,669 shares of Cardinal Health, Inc. (CAH), valued at approximately $44.53 M.
As of the Q4 2025 filing, Cardinal Health, Inc. (CAH) represents approximately 0.16% of Ray Dalio's publicly disclosed stock portfolio, making it one of their key holdings.
Ray Dalio's peak holding in Cardinal Health, Inc. (CAH) was 782,043 shares, as reported at the end of Q4 2018.